New Delivery System For Chemo Treatment Eliminates Bladder Cancer In 82% Of Patients

New Delivery System For Chemo Treatment Eliminates Bladder Cancer In 82% Of Patients

New Delivery System For Chemo Treatment Eliminates Bladder Cancer In 82% Of Patients The TAR-200 bladder cancer treatment – credit, Johnson & Johnson Staggering results have been reported from a clinical trial of a new delivery method for chemotherapy drugs used to treat bladder cancer. Keck Medicine of USC reports that in the majority of cases the cancer disappeared after only three months of treatment, and almost half the patients were cancer-free a year later. The system is called TAR-200, and is composed of a pretzel-shaped delivery device that’s inserted into the bladder. Its slow release of the drug gemcitabine allows this chemotherapy medicine to stay in the organ for days, compared to mere hours as is the case with the current standard-of-care. TAR-200 is designed for treating high-risk and treatment-resistant non-muscle-invasive bladder cancer, the most common form. “Traditionally, these patients have had very limited treatment options. This new therapy is the most effective on…